Ticker
ICCCCompany Name
IMMUCELL CORPSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Interest Expense | Interest Expense Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 0 | 0% | $ 28.27M |
3/31/2025 | $ 0 | 0% | $ 27.3M |
12/31/2024 | $ 0 | 0% | $ 26.49M |
9/30/2024 | $ 0 | 0% | $ 23.84M |
6/30/2024 | $ 0 | 0% | $ 23.22M |
3/31/2024 | $ 0 | 0% | $ 21.28M |
12/31/2023 | $ 0 | 0% | $ 17.47M |
9/30/2023 | $ 0 | 0% | $ 16.29M |
6/30/2023 | $ 0 | 0% | $ 15.69M |
3/31/2023 | $ 0 | 0% | $ 16.01M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. / Revenues
(=) Int. Exp. %
Int. Exp. % for IMMUCELL CORP is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 15.23M ]
(=) Int. Exp. % [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.15K |
---|---|
min | -4.94% |
max | 8.49% |
average | 1.63% |
median | 0.79% |
std | 2.2% |